Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/54227
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Callejas, Nuria A. | |
dc.contributor.author | Castrillo, Antonio | |
dc.contributor.author | Boscá, Lisardo | |
dc.contributor.author | Martín-Sanz, Paloma | |
dc.date.accessioned | 2019-02-18T09:26:02Z | - |
dc.date.available | 2019-02-18T09:26:02Z | - |
dc.date.issued | 1999 | |
dc.identifier.issn | 0022-3565 | |
dc.identifier.uri | http://hdl.handle.net/10553/54227 | - |
dc.publisher | 0022-3565 | |
dc.relation.ispartof | Journal of Pharmacology and Experimental Therapeutics | |
dc.source | Journal of Pharmacology and Experimental Therapeutics[ISSN 0022-3565],v. 288, p. 1235-1241 | |
dc.title | Inhibition of prostaglandin synthesis up-regulates cyclooxygenase-2 induced by lipopolysaccharide and peroxisomal proliferators | |
dc.type | info:eu-repo/semantics/article | |
dc.type | Article | |
dc.identifier.scopus | 0033021515 | |
dc.contributor.authorscopusid | 6602839757 | |
dc.contributor.authorscopusid | 55445301000 | |
dc.contributor.authorscopusid | 35514045400 | |
dc.contributor.authorscopusid | 57196054763 | |
dc.description.lastpage | 1241 | |
dc.description.firstpage | 1235 | |
dc.relation.volume | 288 | |
dc.type2 | Artículo | |
dc.identifier.ulpgc | Sí | es |
dc.description.jcr | 3,3 | |
dc.description.jcrq | Q1 | |
dc.description.scie | SCIE | |
item.grantfulltext | none | - |
item.fulltext | Sin texto completo | - |
crisitem.author.dept | GIR IUIBS: Farmacología Molecular y Traslacional | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.orcid | 0000-0002-2057-2159 | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | Castrillo Viguera,Antonio Jesús | - |
Appears in Collections: | Artículos |
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.